Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model

Global control of tuberculosis (TB), an infectious disease that claims nearly 2 million lives annually, is hindered by the long duration of chemotherapy required for curative treatment. Lack of adherence to this intense treatment regimen leads to poor patient outcomes, development of new or addition...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maiga, Mamoudou, Agarwal, Nisheeth, Ammerman, Nicole C., Gupta, Radhika, Guo, Haidan, Maiga, Marama C., Lun, Shichun, Bishai, William R.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3272040/
https://ncbi.nlm.nih.gov/pubmed/22319585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0030749
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados